Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-002617

Chief Executive Officer acquired 11,806 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2022-01-07 Option exercise +11,806 $5.19 $61,273 4,057,634 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2022-01-07 Option exercise · Stock Option (right to buy Common Stock) −11,806 761,421 D: show line 2 in the form
Loading xslF345X03/doc4.xml…